Arch Biopartners Inc. (TSXV:ARCH)
Canada
· Delayed Price · Currency is CAD 0.770
-0.030 (-3.75%)
At close: Mar 9, 2026
Arch Biopartners Balance Sheet
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0 | 0 | 0 | 0.83 | 0.51 | 0.45 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0 | 0 | 0.83 | 0.51 | 0.45 | Upgrade
|
| Cash Growth | -92.41% | -29.23% | -99.64% | 64.17% | 12.96% | -31.43% | Upgrade
|
| Accounts Receivable | - | - | 0.72 | - | - | 1.85 | Upgrade
|
| Other Receivables | 0.01 | 0.08 | 0.17 | 0.3 | 0.09 | 0.35 | Upgrade
|
| Receivables | 0.01 | 0.08 | 0.9 | 0.3 | 0.09 | 2.2 | Upgrade
|
| Prepaid Expenses | 0.01 | 0.02 | 0.03 | 0.04 | 0.03 | 0.02 | Upgrade
|
| Total Current Assets | 0.03 | 0.1 | 0.94 | 1.17 | 0.62 | 2.67 | Upgrade
|
| Total Assets | 0.03 | 0.1 | 0.94 | 1.17 | 0.62 | 2.67 | Upgrade
|
| Accounts Payable | 0.96 | 1.04 | 2.32 | 0.39 | 0.49 | 0.96 | Upgrade
|
| Accrued Expenses | - | - | 0.04 | 0.17 | 0.19 | 0.42 | Upgrade
|
| Short-Term Debt | 2.63 | 2.84 | 2.27 | 1.71 | - | 1.8 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 0.5 | 2.6 | 2.1 | - | Upgrade
|
| Current Unearned Revenue | 0.03 | 0.1 | 0.15 | 1.1 | - | - | Upgrade
|
| Total Current Liabilities | 3.62 | 3.99 | 5.28 | 5.98 | 2.78 | 3.19 | Upgrade
|
| Long-Term Debt | - | - | - | 0.7 | 2.31 | 3.36 | Upgrade
|
| Total Liabilities | 3.62 | 3.99 | 5.28 | 6.68 | 5.09 | 6.55 | Upgrade
|
| Common Stock | 21.41 | 20.35 | 18.25 | 15.88 | 15.55 | 14.76 | Upgrade
|
| Additional Paid-In Capital | 7.38 | 6.6 | 6.68 | 6.66 | 4.7 | 4.68 | Upgrade
|
| Retained Earnings | -35.08 | -33.52 | -31.97 | -28.05 | -24.72 | -23.32 | Upgrade
|
| Comprehensive Income & Other | 2.69 | 2.69 | 2.69 | - | - | - | Upgrade
|
| Shareholders' Equity | -3.6 | -3.88 | -4.35 | -5.51 | -4.47 | -3.88 | Upgrade
|
| Total Liabilities & Equity | 0.03 | 0.1 | 0.94 | 1.17 | 0.62 | 2.67 | Upgrade
|
| Total Debt | 2.63 | 2.84 | 2.77 | 5.02 | 4.41 | 5.16 | Upgrade
|
| Net Cash (Debt) | -2.63 | -2.84 | -2.77 | -4.18 | -3.91 | -4.72 | Upgrade
|
| Net Cash Per Share | - | -0.04 | -0.04 | -0.07 | -0.06 | -0.08 | Upgrade
|
| Filing Date Shares Outstanding | - | 66.93 | 64.94 | 62.76 | 62.4 | 61.36 | Upgrade
|
| Total Common Shares Outstanding | - | 66.11 | 64.65 | 62.6 | 62.33 | 61.96 | Upgrade
|
| Working Capital | -3.6 | -3.88 | -4.35 | -4.81 | -2.16 | -0.52 | Upgrade
|
| Book Value Per Share | - | -0.06 | -0.07 | -0.09 | -0.07 | -0.06 | Upgrade
|
| Tangible Book Value | -3.6 | -3.88 | -4.35 | -5.51 | -4.47 | -3.88 | Upgrade
|
| Tangible Book Value Per Share | - | -0.06 | -0.07 | -0.09 | -0.07 | -0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.